Kliničke studije za Gliom u državi Tennessee
8 studija za Gliom traži sudionike na lokacijama u državi Tennessee.
Gradovi u državi Tennessee
Službeni tekst studije (engleski)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- East Tennessee Childrens Hospital, Knoxville
- Saint Jude Children's Research Hospital, Memphis
- The Children's Hospital at TriStar Centennial, Nashville
U tijeku regrutacijaFaza 1/2
12 Months – 21 Years · Oba spola · Ažurirano 1. lis 2026. · NCT05099003A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- St. Jude Children's Research Hospital, Memphis
U tijeku regrutacijaFaza 1/2
Do 25 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT04094610SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Vanderbilt-Ingram Cancer Center, Nashville
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. kol 2026. · NCT05303519A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
- SCRI Oncology Partners, Nashville
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 11. kol 2026. · NCT05916313A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- SCRI - TriStar Medical Group Children's Specialists, Nashville
- SCRI Oncology Partners, Nashville
U tijeku regrutacijaFaza 2
Od 8 godina i više · Oba spola · Ažurirano 27. srp 2026. · NCT05503797Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
- Vanderbilt University Medical Center, Nashville
U tijeku regrutacijaRana faza 1
Od 18 godina i više · Oba spola · Ažurirano 1. srp 2026. · NCT07210632Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
- St. Jude Children's Research Hospital, Memphis
U tijeku regrutacijaFaza 2
Do 3 godina · Oba spola · Ažurirano 13. svi 2026. · NCT06528691A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
- SCRI Oncology Partners, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 20. tra 2026. · NCT06326411Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.